[Intraoperative radiation therapy: its technological support, potentials and prospects]
- PMID: 8754122
[Intraoperative radiation therapy: its technological support, potentials and prospects]
Abstract
The authors' experience with intraoperative radiotherapy (IORT) in 129 patients with a tumorous process at various sites has demonstrated that in most clinical events, single radiation doses of 10-20 Gy is insufficient to have a persistent local effect and requires additional pre- or postoperative remote irradiation. The use of IORT as a single component of radiation exposure does not lead to significant radiation damages to normal tissues. When IORT is combined with remote irradiation (the latter using doses of 30-60 Gy), 30% of patients develop radiation-induced normal tissue lesions. In the context of enhancing the local effect and, if possible, decreasing the dose of remote irradiation, it is expedient to increase IORT doses, which is in turn fraught with higher incidence and severity of radiation lesions. In this connection, it seems urgent to have a look for the potentialities to expand the radiotherapeutical range. This follows several directions.
Similar articles
-
[The intraoperative irradiation of tumors].Vopr Onkol. 1992;38(5):585-92. Vopr Onkol. 1992. PMID: 1300758 Russian.
-
Radiation exposure of personnel during intraoperative radiotherapy (IORT): radiation protection aspects.J Exp Clin Cancer Res. 2004 Sep;23(3):489-94. J Exp Clin Cancer Res. 2004. PMID: 15595641
-
Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.Cancer J Sci Am. 1996 Nov-Dec;2(6):321-9. Cancer J Sci Am. 1996. PMID: 9166552
-
Intraoperative radiotherapy: current thinking.Eur J Surg Oncol. 2002 Mar;28(2):180-5. doi: 10.1053/ejso.2001.1161. Eur J Surg Oncol. 2002. PMID: 11884054 Review.
-
History, preliminary results, complications, and future prospects of intraoperative radiotherapy.J Surg Oncol. 1987 Nov;36(3):175-82. doi: 10.1002/jso.2930360306. J Surg Oncol. 1987. PMID: 3119944 Review.